RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Столичная издательская компания
2015-12-01
|
| Σειρά: | Рациональная фармакотерапия в кардиологии |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.rpcardio.online/jour/article/view/510 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|